// App-Quantinova.ai

: A novel hybrid approach to real-world data capture in a mepolizumab study

Researchers

Presenter

  • Sally Worsley

Principal Investigators

  • Carys Bettinson

  • Namhee Kwon

  • Necdet B Gunsoy

  • Nirali Kotowsky

  • Hana Mllerov

  • Donny Chen

  • Margaret Richards

  • Keele Wurst

  • Frank Albers

Medical Centers

  • Real World Delivery, GSK, Uxbridge, United Kingdom

  • Respiratory Medical Franchise, GSK, London, United Kingdom.

  • Clinical Statistics, GSK, Stockley Park, Uxbridge, Middlesex, United Kingdom,

  • Real World Evidence and Epidemiology, GSK Research and Development, Upper Providence, PA, United States of America

  • Real World Evidence and Epidemiology, GlaxoSmithKline plc., Uxbridge, United Kingdom,

  • Medical Affairs Research Operations, PPD Inc, Wilmington, NC, United States of America

  • Respiratory Medical Franchise, GSK, Research Triangle Park, NC, United States,

Locations

  • United Kingdom

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Asthma

Biomarkers

  • Recepteur d'Origine Nantais

Drug/Treatment

  • Mepolizumab

Outcome

  • N/A

Study Design

  • Observational

  • Single Arm

  • Prospective

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved